Following our visit to Cardiff University and Cardiff CLL research CLLSA are pleased to provide you the resulting discussions in Video.
An introduction to Professor Chris Pepper and the Cardiff CLL Research Group
In this first video Professor Chris Pepper of The Cardiff CLL Research Group, Institute of
Cancer & Genetics at Cardiff University tells us a little about himself and how he became
involved in CLL research, the work of the CLL research team and the Cancer Research
Genetics Building and provides us with an overview of the CLL research work of the
Cardiff CLL Group.
The team focus on three main areas of research:
1) Understanding the basic Cell biology of what makes CLL cells grow and resist drugs.
2) Determining prognostic markers to predict how CLL will develop
3) Developing new CLL drugs
What does the future hold for me as a patient?
Significant breakthrough made into improving prognostic testing for patients diagnosed with CLL
In this second video Prof Pepper discusses advances into biological knowledge and therapeutics for CLL, and work being carried out globally including the Cardiff group’s work on CLL prognostic testing over the past ten years and their pivotal study and published paper; "Defining the prognosis of early stage chronic lymphocytic leukaemia patients", two years ago.
Prof Pepper concludes with discussion about the group’s recent CLL prognostic testing breakthrough and study of telemeres. How telomere length can "offer even greater prognostic surety for CLL patients".
Their latest paper was published last Month; "Telomere dysfunction accurately predicts clinical outcome in CLL, even in patients with early stage disease"
As a CLL patient spending time with Prof Pepper left me with a feeling of great optimism as we move into the new world of improved testing and treatment of CLL
Cardiff CLL blogs.cardiff.ac.uk/cardiffcll
The latest Cardiff CLL research paper: Telomere dysfunction accurately predicts clinical
outcome in chronic lymphocytic leukaemia, even in patients with early stage disease
Cardiffs pivotal prognostic paper of two years ago: Defining the prognosis of early stage chronic lymphocytic leukaemia patients. onlinelibrary.wiley.com/doi...